INTERMUNE INC
EXHIBIT 10.47
<DOCUMENT>
<TYPE>EX-10.47
<SEQUENCE>4
<FILENAME>a2082633zex-10_47.htm
<DESCRIPTION>EXHIBIT 10.47
<TEXT>
<HTML>
<HEAD>
<TITLE>
</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P ALIGN="RIGHT"><FONT SIZE=2><B>EXHIBIT 10.47  </B></FONT></P>

<P><FONT SIZE=2>April&nbsp;5,
2002 </FONT></P>

<P><FONT SIZE=2>Marianne
Armstrong, Ph.D<BR>
64 Mountain View Avenue<BR>
Mill Valley, CA 94941 </FONT></P>

<P><FONT SIZE=2>Dear
Marianne: </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
behalf of InterMune,&nbsp;Inc. (the "Company"), we are pleased to offer you the position of Senior Vice President of Global Regulatory Operations and Corporate Compliance, reporting
to Dr.&nbsp;Scott Harkonen, the Company's CEO. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms of your employment will be as follows: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will receive a base salary of $20,000 per month, paid on a semi-monthly basis. In addition, the Company will provide you with a one-time sign-on
bonus of $30,000 (plus tax gross up) to be paid one month following your first day of employment, that is subject to repayment in full if your employment terminates before one year. In the event
Genentech,&nbsp;Inc. requires repayment in full or for any part of the Eighty-Five Thousand Dollar ($85,000) taxable subsidy income afforded to you, then the Company will repay the
requested amount. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Also,
the Company will lend to you $345,000 to repay the interest-free loan of Three Hundred Seventy-Five Thousand Dollars ($375,000) carried by
Genentech,&nbsp;Inc. on your property at 64 Mountain View Avenue, Mill Valley, California. (Based on the terms of the promissory note dated May&nbsp;25, 2000 between yourself and
Genentech,&nbsp;Inc., Thirty Thousand Dollars ($30,000) of the loan was forgiven on May&nbsp;25, 2001.) The term of the loan will be five years, and the other terms and conditions of this loan
will be governed by a loan agreement that you will be required to sign. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a full-time employee of the Company, you will be eligible for the Company's standard benefits package including medical and dental as well as the employee stock purchase
program, 401K Retirement Plan and our Flexible Spending Plan. Your position is exempt, and you will not be eligible for overtime. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to approval of the Compensation Committee of the Company's Board of Directors, you will be granted an option to purchase 85,000 shares of the Company's common stock. Your right
to exercise the shares of this option will be subject to a vesting schedule, such that 85,000 shares of your option will be fully vested at the end of four years completed employment. The grant will
be made by the Compensation Committee of the Company's Board of Directors at its next meeting after your first day of employment. The exercise price will be the same as the closing price of the
Company's Common Stock on the Nasdaq Exchange on the day before the meeting. Your vesting will begin on your first day of your employment with us; however, it is subject to a one-year
cliff. The terms and conditions of this option, including vesting, will be governed by an agreement that you will be required to sign. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a condition of your employment, you will be required to provide proof of U.S. citizenship or that you are legally entitled to work in the United States, and to execute and be bound by
the terms of the enclosed Proprietary Information and Inventions Agreement. In that regard, please be aware that Company policy prohibits all employees from bringing to the Company, or using in
performance of their responsibilities at the Company, any confidential information, trade secrets, or proprietary material or processes of any previous employer. Employment with the Company is at
will, is not for any specific term and can be terminated by you or the Company at any time for any reason with or without cause. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
offer remains open through end of the day April&nbsp;5, 2002. Upon your acceptance of this offer, the terms described in this letter and in the Proprietary Information and
Inventions Agreement shall be the terms of your employment, superseding and terminating any other employment agreements or understandings with InterMune, whether written or oral. Any additions or
modifications of these terms </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2082633",CP="INTERMUNE, INC.",DN="3",CHK=139054,FOLIO='blank',FILE='DISK038:[02SFO4.02SFO1664]KI1664A.;7',USER='CSTCLAI',CD='12-AUG-2002;14:06' -->
<BR>

<P><FONT SIZE=2>
must be in writing and signed by you and an officer of the Company. Your anticipated start date is May&nbsp;1, 2002. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Again,
let me indicate how pleased we are to extend this offer, and how much we at InterMune look forward to working with you. We anticipate that you will find this an exciting and
challenging position in a dynamic and growing company. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
accept this offer by signing and returning the enclosed duplicate original of this letter to me. If you have any questions, please call me or Mireya Ono in the office. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>Very truly yours,</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2><BR>
/s/ Stephen N. Rosenfield<BR>
Stephen N. Rosenfield<BR>
Senior Vice President of Legal Affairs</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" VALIGN="TOP"><BR><FONT SIZE=2><B>UNDERSTOOD AND ACCEPTED:</B></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2><BR>
/s/ Marianne
Armstrong&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4/
18/02</FONT><HR NOSHADE><FONT SIZE=2> Marianne Armstrong,
Ph.D&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=2,EFW="2082633",CP="INTERMUNE, INC.",DN="3",CHK=199902,FOLIO='blank',FILE='DISK038:[02SFO4.02SFO1664]KI1664A.;7',USER='CSTCLAI',CD='12-AUG-2002;14:06' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- SEQ=,FILE='QUICKLINK',USER=CSTCLAI,SEQ=,EFW="2082633",CP="INTERMUNE, INC.",DN="3" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
